Targeting proteins to deliver therapeutic or diagnostic reagents
| dc.contributor.assignee | Board of Regents, Univ. of Tex. Sys. | |
| dc.creator | Lan, Keng-Hsin | |
| dc.creator | Hung, Mien-Chie | |
| dc.creator | Liu, Jaw-Ching | |
| dc.creator | Yang, Fu Ou | |
| dc.date.accessioned | 2019-05-14T14:36:09Z | |
| dc.date.available | 2019-05-14T14:36:09Z | |
| dc.date.filed | 2011-03-15 | |
| dc.date.issued | 2011-03-15 | |
| dc.description.abstract | The present invention is directed to compositions comprising an angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a specific embodiment, the composition is a fusion gene or fusion gene product encoding the angiogenesis inhibitor coupled to a therapeutic or diagnostic agent. In a particular embodiment, the composition is used for methods to treat angiogenesis-related diseases, such as cancer. | |
| dc.description.department | Board of Regents, University of Texas System | |
| dc.identifier.applicationnumber | 11672799 | |
| dc.identifier.patentnumber | 7906628 | |
| dc.identifier.uri | https://hdl.handle.net/2152/74725 | |
| dc.identifier.uri | http://dx.doi.org/10.26153/tsw/1843 | |
| dc.publisher | United States Patent and Trademark Office | |
| dc.relation.ispartof | University of Texas Patents | |
| dc.rights.restriction | Open | |
| dc.subject.cpc | A61K47/66 | |
| dc.subject.cpc | A61K38/00 | |
| dc.subject.cpc | B82Y5/00 | |
| dc.subject.cpc | C07K14/78 | |
| dc.subject.cpc | C07K14/5434 | |
| dc.subject.cpc | C07K2319/32 | |
| dc.subject.cpc | C07K2319/60 | |
| dc.subject.cpc | C07K2319/74 | |
| dc.subject.cpc | C12N9/78 | |
| dc.subject.uspc | 530/402 | |
| dc.subject.uspc | 530/350 | |
| dc.title | Targeting proteins to deliver therapeutic or diagnostic reagents | |
| dc.type | Patent |